Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The ERK5 phosphorylation pathway is a mitogen-activated protein kinase (MAPK) signaling cascade, distinct from other MAPKs due to the unique structure and regulatory mechanisms of its central component, ERK5 (also known as BMK1). This pathway plays critical roles in cell proliferation, differentiation, survival, apoptosis, and angiogenesis. The pathway is activated by upstream kinases like MEKK2/MEKK3, which phosphorylate MEK5, which in turn phosphorylates ERK5 at Thr219 and Tyr221 within the TEY motif. Once activated, ERK5 translocates to the nucleus and phosphorylates transcription factors such as SAP1, c-FOS, and MEF2, regulating gene expression. Dysregulation of the ERK5 pathway contributes to tumorigenesis and resistance to conventional therapies, making it an emerging anti-cancer target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ERK5 Phosphorylation Pathway.